Attack-free status across subgroups of patients with Hereditary Angioedema (HAE) after 96 weeks of berotralstat treatment: results from the APeX-S trial

Authors
Category Primary study
Conference13th C1-Inhibitor Deficiency and Angioedema Workshop - 2023
Year 2023
This article has no abstract
Epistemonikos ID: aee18e183cc4768bb831bc900d93f480c3d3696c
First added on: Mar 14, 2026